Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc Virtual R&D Day Transcript

Dec 06, 2021 / 06:30PM GMT
Release Date Price: €118.5 (+5.01%)
Susan M. Morrison
Tandem Diabetes Care, Inc. - Executive VP & Chief Administrative Officer

Hello. On behalf of the senior management team at Tandem Diabetes Care, we'd like to welcome you to our 2021 R&D Day. I'm Susan Morrison, Executive Vice President and Chief Administrative Officer, and today, we look forward to providing you with greater insight into our strategy and plans for driving near- and longer-term growth through innovation.

It's my pleasure to introduce the Tandem speakers during today's presentation, including John Sheridan, President and CEO; Liz Gasser, Executive Vice President and Chief Strategy Officer; Leigh Vosseller, Executive Vice President and CFO; Dr. Steph Habif, Vice President of Behavioral Sciences; Jordan Pinsker, our Vice President and Medical Director; and Garrett Marin, Head of Product Management.

Today's presentation will be about 2 hours structured in 2 parts with a brief intermission about halfway through. There will be an opportunity for Q&A both prior to intermission and at the end of the presentations. Sell-side analysts who would like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot